CONBA
康恩贝
Established in 1969, CONBA Group is a large pharmaceutical enterprise under its umbrella, focusing on traditional Chinese medicine and modern plant medicine. It integrates drug research and development, production, sales, and the cultivation and extraction of medicinal materials.
Zhejiang CONBA Pharmaceutical Co., Ltd., originally Lanxi Yunshan Pharmaceutical Factory, has grown over more than fifty years into a large-scale pharmaceutical company that integrates drug research and development, production, sales, and the cultivation and extraction of medicinal materials. The company went public on the Shanghai Stock Exchange in April 2004 with the stock code 600572.
The company’s registered office is in Lanxi City, Zhejiang Province, with its management headquarters in Hangzhou, Zhejiang Province. With Zhejiang as its industrial development center, the company has established sizable industrial bases in provinces such as Jiangxi, Yunnan, Guizhou, and Inner Mongolia and owns several sizable and powerful subsidiaries.
As an enterprise centered on traditional Chinese medicine and modern plant medicine, CONBA emphasizes product quality as the cornerstone of its industry and brand management. Upstream in the industrial chain, the company establishes medicinal plant and herbal medicine cultivation bases in environmentally friendly areas to ensure the quality of raw materials. In research and development, the company explores new drug formulation research and the standard enhancement of plant extracts, relying on platforms like the National Enterprise Technology Center, National Postdoctoral Research Station, and National Innovative Enterprise. In production, CONBA ensures product quality with a comprehensive quality control system and international quality standards. In sales, the company has established a widespread offline marketing system throughout China and vigorously explores e-commerce channels, planning and laying out new retail businesses to deepen connections with customers.
Five decades of dedication have forged the foundation of the CONBA brand, earning widespread acclaim and recognition from consumers. Products such as CONBA’s Intestine Inflammation Tablets, Prostate Health Formula, Ginkgo Biloba Preparation, Compound Fishy Grass Preparation, Omeprazole Preparation, Eye Protection Series, and Han’s Pseudostellaria Root all enjoy good reputations in their respective markets and are dominant brands in their segments.
Looking forward, CONBA will focus on its core pharmaceutical business, accelerating the development of over-the-counter medications and health consumer products. It will actively expand its exclusive traditional Chinese medicine and featured generic drugs, continue to develop unique chemical herbal slices, and support the provincial international trade group in establishing dual “flagships” of pharmaceutical R&D and business. The aim is to become a leading company in Zhejiang’s trillion-yuan health industry and one of the leaders in China’s traditional medicine health industry, contributing actively to a healthy Zhejiang and China.
The company boasts a strong team dedicated to the research and development of modern plant medicine and specialty chemical drugs, consisting of personnel with doctoral, master’s degrees, and mid-to-high technical titles. It has established long-term strategic partnerships and alliances with well-known domestic and international research institutions and universities. The company has built multiple technology platforms for new drug R&D and has set up a standardized and efficient industrial system encompassing all stages from medicinal plant cultivation, raw material and plant extraction, new drug R&D, formulation production, to market marketing.
The company has always attached great importance to the cultivation and protection of product and corporate brands, establishing widely recognized and accepted brands in areas such as the urinary and cardiovascular systems. Currently, the company is one of the enterprises in Zhejiang Province with the most famous trademarks and brand products. Among them, “Prostate Health” as the company’s leading plant medicine product has become China’s top brand for treating prostate hyperplasia, and “Ginkgo Preparation” as China’s first modern plant medicine preparation meeting international quality standards is the top brand for Ginkgo Biloba preparations. In addition, brands like “Ale Xin”, “Golden Health”, “Golden Omeprazole”, “Xitao”, “Heavenly Health”, and “Tianshi” all have high brand awareness in their respective fields, establishing prominent brand advantages among competing products.
Best-selling Products from the CONBA Brand：
